What is the price target for CNMD stock?
11 analysts have analysed CNMD and the average price target is 45.08 USD. This implies a price increase of 17.59% is expected in the next year compared to the current price of 38.34.
CONMED CORP (CNMD) Forecast, Price Target & Analyst Ratings
NYSE:CNMD • US2074101013
Current stock price
38.34 USD
+0.84 (+2.24%)
At close:
38.34 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CONMED CORP (CNMD).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 29, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.84
- Revenue Estimate
- 316.72M
Price Target Details & History
Consensus Price Target and Range
Mean target
$45.08
Upside
+ 17.59%
From current price of $38.34 to mean target of $45.08, Based on 11 analyst forecasts
Low
$39.39
Median
$43.86
High
$54.60
Price Target Revisions
1 Month
-6.75%
3 Months
-8.68%
Price Target Summary
11 Wall Street analysts provided a forecast for the next 12 months for CNMD. The average price target is 45.08 USD. This implies a price increase of 17.59% is expected in the next year compared to the current price of 38.34.
The average price target has been revised downward by 8.68% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
50.91%
CNMD was analyzed by 11 analysts. The buy percentage consensus is at 51. So analysts seem to be rather neutral about CNMD.
In the last month the buy percentage fell by 22 points. So the trust of analysts is decreasing.
CNMD was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-17 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2026-01-29 | Needham | Reiterate | Hold -> Hold |
| 2026-01-29 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-08 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-11-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-06 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-06 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-31 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-06-12 | Needham | Downgrade | Buy -> Hold |
| 2025-05-01 | Needham | Maintains | Buy -> Buy |
| 2025-05-01 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-01 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-04-28 | Stifel | Downgrade | Buy -> Hold |
| 2025-02-06 | Needham | Maintains | Buy -> Buy |
| 2025-02-06 | Stifel | Maintains | Buy -> Buy |
| 2025-02-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-06 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-10-31 | Needham | Reiterate | Buy -> Buy |
| 2024-10-04 | Needham | Reiterate | Buy -> Buy |
| 2024-08-01 | Needham | Maintains | Buy -> Buy |
| 2024-08-01 | Stifel | Maintains | Buy -> Buy |
| 2024-08-01 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-07-25 | Needham | Maintains | Buy -> Buy |
| 2024-05-06 | Needham | Reiterate | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 29, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.84
- Revenue Estimate
- 316.72M
- Revenue Q2Q
- -1.41%
- EPS Q2Q
- -12.07%
- Number of Analysts
- 8
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-5.99%
EPS (1 Month)
0.00%
EPS (3 Months)
-11.97%
Next Earnings Summary
CNMD is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is 0.84 USD and the consensus revenue estimate is 316.72M USD.
The next earnings revenue estimate has been revised downward by 5.99% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates 2026 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.245B 19.06% | 1.307B 5.00% | 1.375B 5.18% | 1.386B 0.82% | 1.462B 5.48% | 1.55B 6.02% | |
| EBITDA YoY % growth | 193.277M 38.35% | 281.059M 45.42% | 179.903M -35.99% | 272.75M 51.61% | 298.8M 9.55% | 321.3M 7.53% | |
| EBIT YoY % growth | 121.403M 73.19% | 209.202M 72.32% | 105.622M -49.51% | 208.93M 97.81% | 227.72M 8.99% | 245.03M 7.60% | |
| Operating Margin | 9.75% | 16.01% | 7.68% | 15.07% | 15.58% | 15.81% | |
| EPS YoY % growth | 3.45 30.19% | 4.16 20.58% | 4.61 10.82% | 4.44 -3.63% | 5.03 13.12% | 5.66 12.64% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.84 -12.07% | 1.11 -3.32% | 1.07 -1.21% | 1.43 -0.02% | 1.03 23.00% | 1.25 12.84% | 1.21 13.35% | 1.56 8.89% |
| Revenue Q2Q % growth | 316.72M -1.41% | 347.44M 1.49% | 341.57M 1.08% | 380.11M 1.85% | 334.97M 5.76% | 370.46M 6.63% | 358.94M 5.09% | 398.21M 4.76% |
| EBITDA Q2Q % growth | 56.196M 42.26% | 68.289M -18.86% | 65.992M -1.96% | 82.5M -24.41% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 38.97M 83.40% | 49.925M 5.45% | 48.046M 304.46% | 62.359M 78.90% | 44.882M 15.17% | 57.046M 14.26% | 54.202M 12.81% | 71.671M 14.93% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
7.09%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
3.55%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
14.30%
EBIT Next 5 Year
N/A
CONMED CORP / CNMD Forecast FAQ
Can you provide the upcoming earnings date for CONMED CORP?
CONMED CORP (CNMD) will report earnings on 2026-04-29, after the market close.
Can you provide the consensus estimates for CONMED CORP next earnings?
The consensus EPS estimate for the next earnings of CONMED CORP (CNMD) is 0.84 USD and the consensus revenue estimate is 316.72M USD.
How do analysts rate CONMED CORP (CNMD)?
The consensus rating for CONMED CORP (CNMD) is 50.9091 / 100 . This indicates that analysts generally have a neutral outlook on the stock.